Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;41(13):1694-1700.
doi: 10.1002/pd.6050. Epub 2021 Oct 7.

Cell-free DNA screening for fetal aneuploidy using the rolling circle method: A step towards non invasive prenatal testing simplification

Enza Pavanello  1 , Andrea Sciarrone  2 , Varvara Guaraldo  1 , Elisabetta Muccinelli  1 , Valentina Pia Ciuffreda  1 , Pina Sauro  1 , Giulia Bondielli  1 , Sandra Mirante  1 , Giulio Mengozzi  1 , Elsa Viora  2 , Howard Cuckle  3 , Barbara Pasini  1   4
Affiliations

Cell-free DNA screening for fetal aneuploidy using the rolling circle method: A step towards non invasive prenatal testing simplification

Enza Pavanello et al. Prenat Diagn. 2021 Dec.

Abstract

Objective: To assess the efficacy of cell-free (cf)DNA screening for aneuploidy using the automated system based on rolling circle replication.

Methods: A prospective study among women referred for invasive prenatal diagnosis between July 2018 and December 2019. The plasma fraction was extracted within 5 days from blood collection, stored at -20°C and cfDNA measured between January and December 2019.

Results: A total of 805 women were recruited; 778 with singleton pregnancies and 27 twins. There were 48 Down syndrome, 25 Edwards syndrome and 3 Patau syndrome cases. Overall, the no-call rate was 2.6% (95% confidence interval 1.6%-3.9%) which reduced from 4.7% to 1.1% after relocation of the system (p < 0.002) to ensure a constant ambient temperature below 25°C. In singletons the Down syndrome detection rate (DR) was 100% (93%-100%) and false-positive rate (FPR) 0.14% (0.00%-0.79%). The Edwards syndrome DR was 96% (80%-100%) and FPR 0.78% (0.29%-1.7%). One false-positive had a confined placental trisomy 18 and the remaining five a z-score requiring sample repetition; all the false-positives occurred before system relocation (p < 0.005). Patau syndrome DR and FPR were 67% (9.4%-99%) and 0.26% (0.03%-0.95%).

Conclusion: The cfDNA rolling circle method yields similar results to other methods provided that room temperature is adequately controlled.

PubMed Disclaimer

References

REFERENCES

    1. Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2017;50(3):302-314.
    1. Ginsberg GM, Cuckle H. Cost-utility analysis of cfDNA screening for Down's syndrome in Israel. In: Studd J, Tan SL, Chevenak FA, eds. Current Progress in Obstetrics and Gynecology. Vol 4. Kothari Medical; 2017.
    1. Dahl F, Ericsson O, Karlberg O, et al. Imaging single DNA molecules for high precision NIPT. Sci Rep. 2018;8(1):4549.
    1. Ericsson O, Ahola T, Dahl F, et al. Clinical validation of a novel automated cell-free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma. Prenat Diagn. 2019;39(11):1011-1015.
    1. Cuckle H, Benn P. Maternal plasma cell-free DNA screening: integration into clinical practice. In: Hod M, Berghella V, D’Alton M, Di Renzo GC, Gratacos E, Fanos V, eds. New Technologies and Perinatal Medicine. CRC Press; 2020.

Substances

LinkOut - more resources